Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet. 2004 Dec 15; 13(24):3029-43.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Drug Resistance, Neoplasm
ErbB Receptors
Female
Humans
Immunohistochemistry
Male
Middle Aged
Oligonucleotide Array Sequence Analysis
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-akt
Quinazolines
Reverse Transcriptase Polymerase Chain Reaction
authors with profiles
Yusuke Nakamura